CQ27. What Are the Incidences of Diseases Associated with Hereditary Medullary Carcinoma?

  • Shinya Uchino
  • Daishu Miura
  • Takahiro Okamoto


Hereditary medullary carcinoma is known to have various associated diseases. Their details and incidences were investigated. Special attention should be paid to the fact that the incidences of associated diseases vary according to whether the RET testing is performed, the diagnostic accuracy of the RET testing, and the definition of MEN and FMTC.


Primary Hyperparathyroidism Medullary Carcinoma Associate Disease Skeletal Abnormality Bodily Characteristic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Eng C, Clayton D, Schuffenecker I et al (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575–1579 (CS)PubMedCrossRefGoogle Scholar
  2. 2.
    Frank-Raue K, Höppner W, Frilling A et al (1996) Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab 81:1780–1783 (CS)PubMedCrossRefGoogle Scholar
  3. 3.
    Schuffenecker I, Virally-Monod M, Brohet R et al (1996) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D’etude des Tumeurs a Calcitonine. J Clin Endocrinol Metab 83:487–491 (CS)CrossRefGoogle Scholar
  4. 4.
    Quayle FJ, Fialkowski EA, Benveniste R et al (2007) Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery 142:800–805, discussion 805 e1 (CS)PubMedCrossRefGoogle Scholar
  5. 5.
    Yip L, Cote GJ, Shapiro SE et al (2003) Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Arch Surg 138:409–416, discussion 416 (CS)PubMedCrossRefGoogle Scholar
  6. 6.
    Iihara M, Yamashita T, Okamoto T et al (1997) A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan. Jpn J Clin Oncol 27:128–134 (CS)PubMedCrossRefGoogle Scholar
  7. 7.
    Decker RA, Peacock ML (1998) Occurrence of MEN 2a in familial Hirschsprung’s disease: a new indication for genetic testing of the RET proto-oncogene. J Pediatr Surg 33:207–214 (CS)PubMedCrossRefGoogle Scholar
  8. 8.
    Howe JR, Norton JA, Wells SA Jr (1993) Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery 114:1070–1077 (CS)PubMedGoogle Scholar
  9. 9.
    Verga U, Fugazzola L, Cambiaghi S et al (2003) Frequent association between MEN 2A and cutaneous lichen amyloidosis. Clin Endocrinol (Oxf) 59:156–161 (CS)CrossRefGoogle Scholar
  10. 10.
    Vasen HF, van der Feltz M, Raue F et al (1992) The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases. Arch Intern Med 152:1250–1252 (CS: Case Series)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  1. 1.Department of SurgeryNoguchi Thyroid Clinic and Hospital FoundationBeppuJapan
  2. 2.Department of Breast and Endocrine SurgeryToranomon HospitalTokyoJapan
  3. 3.Department of Endocrine Surgery and Hygiene & Public Health IITokyo Women’s Medical UniversityTokyoJapan

Personalised recommendations